A shortage of environmental allergy vaccine at the National Institute of Health has left hundreds of patients unable to receive treatment as temperatures fell.
Allergy centres now provide testing only, and patients from across the country returned home without receiving the vaccine, the details said on Wednesday.
The National Health Institute required more than six hundred vaccine doses each day to meet demand from patients arriving from various cities.
Patients suffering with asthma, cold, flu, eye allergies and other respiratory or throat conditions have been left without access to the allergy vaccine.
Read More: https://newztodays.com/calls-for-regulation-as-surgical-births-rise/
The number of patients waiting for the allergy vaccine has reached four thousand, and the cost of a single vaccine is 1,000.
Dr Mohammad Salman, CEO of the National Health Institute, confirmed the shortage and said a chemical issue had delayed the vaccine’s post-production stage.
He assured that the remaining vaccines are available, and he said prompt availability of the allergy vaccine will be ensured for waiting patients.
